HARTFORD INSURANCE GROUP, INC.
HIGBusiness Summary
The Hartford Insurance Group, Inc. operates in the property and casualty insurance and employee benefits industries. The filing describes the company as a provider of property and casualty insurance, group benefits, and mutual funds, serving both business and personal customers across the United States.
The filing does not name specific primary competitors or provide market share data. It describes competitive advantages as including a strong brand, a broad distribution network, and a focus on underwriting discipline and customer service.
The Hartford generates revenue primarily through the collection of premiums from property and casualty insurance policies and from fees earned on group benefits and mutual fund products. The company's revenue is a mix of recurring premium income and transactional fee income. Its primary customer segments include small and middle-market businesses, as well as individuals seeking personal auto, homeowners, and group benefits coverage.
The company's Commercial Lines segment includes workers' compensation, property, marine, package business, general liability, professional liability, surety, and assumed reinsurance. For the year ended December 31, 2025, Commercial Lines earned premiums of $12.575 billion 1. The Personal Lines segment provides private passenger auto and homeowners insurance, with earned premiums of $3.575 billion 2 for the same period. The Group Benefits segment offers group disability, life, and other benefits, generating earned premiums of $5.364 billion 3 and administrative services fees of $0.340 billion 4 in 2025. The Hartford Funds segment provides investment management and advisory services, earning investment management and other fees of $0.598 billion 5 in 2025.
The filing does not describe any specific product launches, acquisitions, partnerships, or restructuring actions taken during the period. It does discuss capital actions, noting that the company paid common stock dividends of $0.470 per share 6 in the fourth quarter of 2025 and $1.880 per share 7 for the full year 2025. The company also repurchased 7.9 million 8 common shares for $1.0 billion 9 during 2025.
For the year ended December 31, 2025, total revenues were $25.486 billion 10, compared to $24.726 billion 11 in 2024. Net income was $3.137 billion 12 in 2025, up from $2.495 billion 13 in 2024. Diluted earnings per share were $10.47 14 in 2025 versus $8.14 15 in 2024. The company reported net cash provided by operating activities of $4.423 billion 16 in 2025.
Business Outlook
The filing does not discuss specific growth vectors such as new products, new markets, or geographic expansion with quantified opportunity sizes.
The filing does not discuss specific growth vectors such as new customer segments, strategic partnerships, or pending acquisitions with quantified opportunity sizes.
The filing does not provide a specific margin or cost outlook with exact figures.
The filing does not discuss operational outlook topics such as supply chain, manufacturing capacity, technology infrastructure investments, or workforce strategy.
The filing does not provide specific R&D spending levels, capital expenditure plans, or share repurchase authorization amounts beyond the executed repurchases. The company paid common stock dividends of $0.470 per share 17 in the fourth quarter of 2025 and $1.880 per share 18 for the full year 2025.
The filing does not discuss structural headwinds or execution risks explicitly flagged to the growth plan.
The filing does not discuss geographic, regulatory, or macro factors management identified as constraints.
Risk Factors
The company faces significant risk from adverse loss reserve development, particularly for asbestos and environmental claims, with net asbestos and environmental loss reserves of $1.0 billion 19 as of December 31, 2025. The company is also exposed to catastrophe losses, with catastrophe losses of $0.7 billion 20 in 2025. Investment portfolio risk is material, as the company held $78.383 billion 21 in total investments, with a significant allocation to fixed maturities and commercial mortgage loans. The company's commercial mortgage loan portfolio had a carrying value of $4.5 billion 22 as of December 31, 2025, with exposure to office properties of $0.8 billion 23. A downgrade in the company's financial strength ratings could materially impact its competitive position and ability to write new business.
Management Priorities
Management's message emphasizes the company's strong financial performance in 2025, highlighting record core earnings and a focus on underwriting discipline. The filing states that the company's book value per diluted share was $56.89 24 as of December 31, 2025. Management's strategic priorities include maintaining underwriting profitability, growing in targeted market segments, and returning capital to shareholders through dividends and share repurchases.
View Source Annual Report on SEC.gov ↗
References
- [1] Item 7, MD&A — Segment Results
- [2] Item 7, MD&A — Segment Results
- [3] Item 7, MD&A — Segment Results
- [4] Item 7, MD&A — Segment Results
- [5] Item 7, MD&A — Segment Results
- [6] Item 8, Note 18 — Shareholders' Equity
- [7] Item 8, Note 18 — Shareholders' Equity
- [8] Item 8, Note 18 — Shareholders' Equity
- [9] Item 8, Note 18 — Shareholders' Equity
- [10] Item 7, MD&A — Consolidated Results
- [11] Item 7, MD&A — Consolidated Results
- [12] Item 7, MD&A — Consolidated Results
- [13] Item 7, MD&A — Consolidated Results
- [14] Item 8, Note 14 — Earnings Per Share
- [15] Item 8, Note 14 — Earnings Per Share
- [16] Item 7, MD&A — Liquidity and Capital Resources
- [17] Item 8, Note 18 — Shareholders' Equity
- [18] Item 8, Note 18 — Shareholders' Equity
- [19] Item 8, Note 10 — Reserve for Losses and Loss Adjustment Expenses
- [20] Item 7, MD&A — Segment Results
- [21] Item 8, Note 4 — Investments
- [22] Item 8, Note 4 — Investments
- [23] Item 8, Note 4 — Investments
- [24] Item 7, MD&A — Consolidated Results
- [25] Item 7, MD&A — Consolidated Results
- [26] Item 7, MD&A — Consolidated Results
- [27] Item 7, MD&A — Consolidated Results
- [28] Item 7, MD&A — Consolidated Results
- [29] Item 8, Note 14 — Earnings Per Share
- [30] Item 8, Note 14 — Earnings Per Share
- [31] Item 7, MD&A — Liquidity and Capital Resources
- [32] Item 7, MD&A — Liquidity and Capital Resources
- [33] Item 8, Note 4 — Investments
- [34] Item 8, Note 12 — Debt
- [35] Item 7, MD&A — Segment Results
- [36] Item 7, MD&A — Segment Results
- [37] Item 7, MD&A — Consolidated Results
- [38] Item 7, MD&A — Consolidated Results
- [39] Item 7, MD&A — Consolidated Results
- [40] Item 7, MD&A — Consolidated Results
Analysis on 6/21/2026